Matristem Pelvic Floor Matrix

The primary objective of this study is to assess the safety and effectiveness of matristem pelvic floor matrix as compared to native tissue repair for the treatment of pelvic organ prolapse.

Matristem pelvic floor matrix.

Acell matristem pelvic floor matrix versus native tissue repair comparative study. Gmdn preferred term name gmdn definition. Pelvic organ prolapse stress urinary incontinence surgical mesh. Matristem surgery matrix rs psm psmx matristem pelvic floor matrix.

The primary objective of this study is to assess the safety and effectiveness of matristem pelvic floor matrix as compared to native tissue repair for the treatment of pelvic organ prolapse. Accessgudid matristem 00386190000847 pelvic floor matrix 5 x 5 cm. Matristem pelvic floor matrix is specifically intended for implantation to reinforce soft tissue where weakness exists in gynecological anatomy including vaginal prolapse repair reconstruction of. Matristem pelvic floor matrix is a naturally occurring non synthetic scaffold that provides a unique balance of strength and pliability for use in repair of anterior posterior and apical defects.

Patients with known sensitivity or allergy to porcine materials. Matristem pelvic floor matrix is intended for implantation to reinforce soft tissue where weakness exists in urological and gynecological anatomy including vaginal prolapse repair reconstruction of pelvic floor and pubourethral support. Do not use device. The primary objective of this study is to assess the safety and effectiveness of matristem pelvic floor matrix as compared to native tissue repair for the treatment of pelvic organ prolapse.

Matristem pelvic floor matrix 6 layer is intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological or gynecological surgery. Patients are evaluated throughout a 3 year follow up period. Matristem pelvic floor matrix is a naturally occurring non synthetic scaffold that provides a unique balance of strength and pliability for use in repair of anterior posterior and apical defects. Patients are evaluated throughout a 3 year follow up period.